The FDA has cleared Siemens Healthcare's Biograph TruePoint 16-slice PET/CT system, which offers PET and routine 10-minute, whole-body imaging and is available with the company's TrueV extended PET field-of-view technology. Siemens also has filed an exploratory Investigational New Drug application for [18F]-SMIBR-W372, a new imaging agent for amyloid plaque, which is linked to Alzheimer's disease.

Full Story:

Related Summaries